Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
PTC Showcases Intelligent Product Lifecycle Vision with Lamborghini at CES 2026 Life Science Investing
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease Life Science Investing
"Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine Biotech Investing
PTC Extends Cloud-Native CAD, PDM, and PLM to Regulated Industries with Onshape Government and Arena GovCloud Connection on AWS Life Science Investing
PTC's Windchill+ Powering HOLON's Development of One of the World's First Automotive-Standard Level-4 EVs Life Science Investing
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. Life Science Investing
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 Biotech Investing
